Since our founding in 2003, Cure JM has accomplished the following thanks to the Juvenile Myositis community, family, and friends:
- Invested over $21 million in research, education, and family support, making Cure JM the world’s largest funder of Juvenile Myositis research.
- Funded over 180 defining research studies resulting in improved treatments and moving us closer to a cure.
- Created resources and connections for over 4,000 patients and families in 40 different countries..
- Currently funding research at 24 prestigious research institutions in four countries.
- Created and provided financial support to the following five Centers of Excellence to advance research and deliver world-class care: George Washington University Hospital, Lurie Children’s Hospital, Seattle Children’s Hospital, Duke Children’s Hospital, and University of California San Francisco.
- Developed a Medical Advisory Board comprised of the leading JM experts in the world.
- Funded breakthrough genetic studies at the renowned Center for Applied Genomics at Children’s Hospital of Philadelphia to better understand the complex genetics of JM, which is critical to identifying targets for improved drug interventions.
- Identified new drug candidates through the Cure JM-funded drug discovery project at the National Center for Advancing Translational Sciences at NIH.
- Engaged with 19,000+ followers in Cure JM’s social media communities.
- Created more than 20 regional chapters across the U.S.
- Created a support network for parents to engage with and learn from other parents.
- Implemented a peer mentor program for older teens to mentor younger teens living with JM.
- Funded a research study with Duke University and CARRA, the Childhood Arthritis and Rheumatology Research Alliance, to determine the best treatment approaches for JM.
- Funded the first-ever book about JM—Myositis and You. Those who join Cure JM can request a complimentary digital copy.
- Host annual Global Symposium on Myositis for clinicians and researchers.
